The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D01 | Antifungals for dermatological use | |
| 3 | D01A | Antifungals for topical use | |
| 4 | D01AC | Imidazole and triazole derivatives | |
| 5 | D01AC14 | Sertaconazole |
| Active Ingredient | Description | |
|---|---|---|
| Sertaconazole |
Sertaconazole, an azole antifungal agent, inhibits fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylase enzyme. This enzyme functions to convert lanosterol to ergosterol. Ergosterol is a key component of fungal cell membranes and lack of this component leads to fungal cell injury by leakage of key constituents in the cytoplasm from the cell. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ERTACZO Cream | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
